FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

734973002: Tenofovir alafenamide fumarate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3512204016 Tenofovir alafenamide fumarate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3512205015 Tenofovir alafenamide fumarate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
25291000188113 ténofovir alafénamide fumarate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844211000172118 fumarate de ténofovir alafénamide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenofovir alafenamide fumarate (substance) Is a Tenofovir alafenamide (substance) false Inferred relationship Some
Tenofovir alafenamide fumarate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Reverse transcriptase inhibitor (disposition) true Inferred relationship Some
Tenofovir alafenamide fumarate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tenofovir alafenamide (substance) true Inferred relationship Some
Tenofovir alafenamide fumarate (substance) Is a Carboxylic ester (substance) true Inferred relationship Some
Tenofovir alafenamide fumarate (substance) Is a Transferase inhibitor false Inferred relationship Some
Tenofovir alafenamide fumarate (substance) Is a Reverse transcriptase inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir alafenamide fumarate (substance) Inferred relationship Some 1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir alafenamide fumarate (substance) Inferred relationship Some 4
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir alafenamide fumarate (substance) Inferred relationship Some 2
Emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir alafenamide fumarate (substance) Inferred relationship Some 2
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir alafenamide fumarate (substance) Inferred relationship Some 2
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tenofovir alafenamide fumarate (substance) Inferred relationship Some 3

Reference Sets

GB English

US English

Back to Start